CD8A and breast cancer: It has also been well confirmed that the antitumor response can be facilitated by inducing T follicular helper cell to activate B cells with immune checkpoint therapy in breast cancer murine models [46], and T follicular helper cells potently enhance the effector functions of CD8 T cells via an IL-21-dependent pathway in colorectal cancer [26].